Bongo Rx rates high in survey

Friday, September 20, 2019

DEERFIELD BEACH, Fla. – More than 70% of 200 people with mild to moderate sleep apnea who were recently surveyed would prefer to try the Bongo Rx over traditional CPAP therapy if given the choice, according to AirAvant Medical, maker of the Bongo Rx. “I feel the results of the Qualtrics Survey reflect that mild to moderate OSA sufferers want a simple and effective alternative to traditional CPAP,” said Bruce Sher, president of AirAvant Medical. “It’s gratifying that years of effort by our team to develop the Bongo Rx have yielded such a great outcome.” The survey was conducted Sept. 4-11. The Bongo Rx is a small nasal device that doesn’t require a CPAP device, mask, hose, headgear, electricity or power.